MARTHA V ROSTRAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MIAMI, FL NPI 1083086722

General Payments — all program years on this page

$15,209.36

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 189
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $908.17 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $908.1721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $7,044.1883
2022 $5,742.6544
2023 $1,514.3641
2024 $908.1721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1117369663 Amgen Inc. $48.13 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117369665 Amgen Inc. $42.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124038231 Vifor Pharma, Inc. $6.59 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124039043 Vifor Pharma, Inc. $1.79 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124043139 Vifor Pharma, Inc. $4.48 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124052145 Vifor Pharma, Inc. $136.84 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124059478 Vifor Pharma, Inc. $96.60 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127053469 Kyowa Kirin, Inc. $24.00 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141514397 CALLIDITAS THERAPEUTICS US INC. $124.97 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145827640 AKEBIA THERAPEUTICS INC $21.52 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145827642 AKEBIA THERAPEUTICS INC $24.07 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145829528 AKEBIA THERAPEUTICS INC $24.07 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146744068 Ardelyx, Inc. $117.12 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146744070 Ardelyx, Inc. $23.81 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193556 Fresenius USA Marketing, Inc. $7.28 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193558 Fresenius USA Marketing, Inc. $19.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193560 Fresenius USA Marketing, Inc. $20.05 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193562 Fresenius USA Marketing, Inc. $20.63 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193564 Fresenius USA Marketing, Inc. $20.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154193566 Fresenius USA Marketing, Inc. $98.17 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154920592 Cycle Pharmaceuticals Inc $25.00 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.